Literature DB >> 3932299

Structure activity relationships in lincosamide and streptogramin antibiotics.

F Le Goffic.   

Abstract

Lincomycin is a 6-amino, 6-deoxy-octopyraninose with strong antibiotic activity. To maintain or enhance this activity, one must have the configuration of the first five asymmetric carbons of the sugar residue with the thioglycolic moiety in the alpha-position. The nitrogen on carbon 6 with the R configuration is also a prerequisite for the activity. Substitutions at the level of C-7 as well as the pyrolidine moiety can dramatically enhance this activity. The streptogramin group is composed of a wide variety of structures which can be classified into two subgroups. Group A or M is composed of polyunsaturated cyclic peptolides, e.g. pristinamycin IIA; group B or S is composed of cyclic hexadepsipeptides. Separately, these molecules have a bacteriostatic activity on Gram-positive organisms, whereas in association they exhibit a strong and synergistic bactericidal effect. The 13-OH function of PIIA is essential for antibiotic activity to occur whereas the 15-carbonyl function can be reduced with the retention of the biological properties of the drug. The carbonyl function of PIA can be reduced and the pipecolic moiety can be replaced by other groups without a dramatic influence on the antibiotic activity. The macrocyclic lactone ring is necessary for antibiotic activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3932299     DOI: 10.1093/jac/16.suppl_a.13

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro.

Authors:  C E Nord; A Lindmark; I Persson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Synthesis and antibacterial activity of novel lincomycin derivatives. I. Enhancement of antibacterial activities by introduction of substituted azetidines.

Authors:  Ko Kumura; Yoshinari Wakiyama; Kazutaka Ueda; Eijiro Umemura; Takashi Watanabe; Eiki Shitara; Hideki Fushimi; Takuji Yoshida; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2016-01-13       Impact factor: 2.649

3.  Comparative in vitro activities of pristinamycin and other antimicrobial agents against genital pathogens.

Authors:  J C Lefevre; R Bauriaud
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

4.  In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin and pristinamycin.

Authors:  M Drancourt; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

5.  Synthesis and antibacterial activity of novel lincomycin derivatives. IV. Optimization of an N-6 substituent.

Authors:  Ko Kumura; Yoshinari Wakiyama; Kazutaka Ueda; Eijiro Umemura; Yoko Hirai; Keiko Yamada; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-11-08       Impact factor: 2.649

6.  Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.

Authors:  J P Maskell; A M Sefton; J Yong; S J Chi; J D Williams
Journal:  Infection       Date:  1988       Impact factor: 3.553

7.  Synthesis and antibacterial activity of novel lincomycin derivatives. III. Optimization of a phenyl thiadiazole moiety.

Authors:  Ko Kumura; Yoshinari Wakiyama; Kazutaka Ueda; Eijiro Umemura; Takashi Watanabe; Mikio Yamamoto; Takuji Yoshida; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-07-05       Impact factor: 2.649

8.  Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.

Authors:  Tim R H Read; Jørgen S Jensen; Christopher K Fairley; Mieken Grant; Jennifer A Danielewski; Jenny Su; Gerald L Murray; Eric P F Chow; Karen Worthington; Suzanne M Garland; Sepehr N Tabrizi; Catriona S Bradshaw
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

Review 9.  Chiral Alkyl Halides: Underexplored Motifs in Medicine.

Authors:  Bálint Gál; Cyril Bucher; Noah Z Burns
Journal:  Mar Drugs       Date:  2016-11-04       Impact factor: 5.118

10.  Structural insights of lincosamides targeting the ribosome of Staphylococcus aureus.

Authors:  Donna Matzov; Zohar Eyal; Raphael I Benhamou; Moran Shalev-Benami; Yehuda Halfon; Miri Krupkin; Ella Zimmerman; Haim Rozenberg; Anat Bashan; Micha Fridman; Ada Yonath
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.